Medical Cannabis Dosing for Chronic Pain UK

Medical Cannabis Dosing Guide for Chronic Pain in the UK

Medical Disclaimer: This guide is for informational purposes only and does not constitute medical advice. Always consult with your UK-registered prescriber before starting, adjusting, or stopping any medical cannabis treatment. Individual responses to cannabis vary significantly based on genetics, tolerance, body weight, and existing medications. This information reflects current UK prescribing practices but regulations and clinical evidence continue to evolve.

Understanding Chronic Pain and Medical Cannabis
Chronic pain affects millions of UK patients and can significantly impact quality of life. When conventional treatments fail to provide adequate relief, medical cannabis has emerged as a potential therapeutic option. Chronic pain conditions that may benefit from medical cannabis include neuropathic pain, rheumatoid arthritis, fibromyalgia, cancer-related pain, and pain following surgery or injury.

Medical cannabis contains two primary active compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). CBD is non-intoxicating and may provide anti-inflammatory and analgesic effects, while THC is psychoactive but also offers pain relief and relaxation properties. The ratio of these compounds in prescribed products varies depending on the specific formulation and your clinical needs.

For chronic pain management, UK prescribers typically recommend products containing both CBD and THC, as evidence suggests the combination may be more effective than either compound alone—a phenomenon known as the “entourage effect.” However, individual patient profiles and medical histories determine the most appropriate product selection.

UK Prescribing Approach: Start Low, Go Slow

The fundamental principle guiding UK medical cannabis prescribing is “start low, go slow.” This conservative approach prioritises patient safety and tolerability while allowing the body to gradually adapt to the medication.

Rather than immediately prescribing a standard adult dose, UK clinicians begin with the lowest effective dose and increase it incrementally over weeks or months. This approach minimises adverse effects, allows patients to identify their optimal therapeutic dose, and helps monitor for any unexpected reactions or drug interactions.

Your prescriber will typically schedule follow-up appointments or telephone consultations to assess your response, discuss any side effects, and make adjustments as needed. This personalised titration process is essential because cannabis response varies considerably between individuals.

To learn more about obtaining a medical cannabis prescription in the UK, visit our guide to getting a cannabis prescription.

Typical Dose Ranges for Chronic Pain

Initial Starting Doses:

For new patients, UK prescribers typically begin with very low doses. Initial CBD doses might range from 2.5mg to 10mg daily, while THC starting doses usually fall between 1mg and 5mg daily. These modest amounts allow your system to acclimate to the medication.

Maintenance Dose Ranges:

After titration, maintenance doses for chronic pain commonly range between 10-40mg of CBD daily and 5-20mg of THC daily. Some patients find relief at these moderate levels and experience minimal side effects. However, others may require higher doses to achieve adequate pain control.

Higher Therapeutic Ranges:

For patients with severe or refractory chronic pain, doses may be titrated higher—potentially reaching 80-160mg of CBD and 20-40mg of THC daily. However, doses exceeding these ranges require careful medical supervision and should only be considered when lower doses prove insufficient.

It’s crucial to note that higher doses don’t automatically produce better results. Some patients experience diminishing returns or increased side effects at elevated doses. Your prescriber will help identify your optimal dose rather than assuming “more is better.”

Routes of Administration

Cannabis Oil (Sublingual)

Cannabis oil administered sublingually (under the tongue) is the most commonly prescribed form in the UK. Drops are placed under the tongue and held there for 60-90 seconds before swallowing. This route allows for precise dosing and relatively rapid absorption within 15-45 minutes. Effects typically peak within 2-3 hours and last 6-8 hours. This makes oil ideal for patients requiring consistent symptom management throughout the day.

Dried Flower (Inhalation)

Some UK patients receive dried cannabis flower prescribed for vaporisation or smoking. This route provides rapid onset (within 5-15 minutes) and shorter duration (2-4 hours), making it useful for acute pain flare-ups. Vaporisation is preferred over smoking to minimise respiratory irritation. However, dosing precision is lower with flower compared to oils or capsules.

Capsules

Cannabis in capsule form provides consistent, measured doses and is convenient for patients on strict regimens. Capsules are absorbed through the digestive system, resulting in slower onset (45 minutes to 2 hours) but longer duration (6-10 hours). This makes capsules suitable for maintaining stable medication levels, particularly for overnight pain management.

Titration Schedule and Adjustment Protocol

A typical titration schedule involves increasing your dose every 3-7 days, depending on your response and tolerance. Your prescriber may recommend increasing by small increments—for example, adding 2.5mg of CBD or 1mg of THC at each step.

Keep a detailed pain journal documenting pain levels, side effects, medication times, and any other relevant observations. This information helps your prescriber make informed decisions about dose adjustments. Many patients find that regular journaling also helps them recognise patterns in their pain and identify optimal dosing times.

Once you reach a dose providing adequate pain relief with tolerable side effects, this becomes your maintenance dose. However, ongoing monitoring remains important, as your needs may change over time.

When to Contact Your UK Prescriber

Contact your prescriber immediately if you experience:

Severe dizziness, confusion, or disorientation
Significant mood changes, anxiety, or paranoia
Signs of allergic reaction (rash, swelling, difficulty breathing)
Interaction concerns if starting new medications
Worsening pain despite dose increases
Persistent nausea or vomiting
Thoughts of self-harm

Schedule routine appointments if experiencing mild but bothersome side effects, wanting to adjust your dose, or needing clarification about your medication. Regular communication with your medical team ensures your treatment remains safe and effective.

Legal and Regulatory Considerations

In the UK, medical cannabis is only legal when prescribed by a registered medical professional. Possession without a valid prescription remains illegal. Since November 2018, specialist doctors can prescribe cannabis-derived medicines following the change in scheduling, but access remains restricted and typically involves specialist clinics.

Your prescription is valid only for the specific product and dose prescribed. Never share your medication with others or use it for purposes other than those prescribed. For comprehensive information about the UK medical cannabis landscape, consult our medical cannabis UK overview.

Conclusion

Medical cannabis offers a potential therapeutic option for UK patients with chronic pain inadequately controlled by conventional treatments. Successful dosing requires partnership between patient and prescriber, patience through the titration process, and careful monitoring of your individual response. Remember that your optimal dose may differ significantly from others’, and ongoing communication with your healthcare team remains essential for safe, effective pain management.